Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patients

• Main Authors: Michael Kwan Leung Yu (Author), Sophelia Hoi Shan Chan (Author), Daniel Leung (Author), Samuel Cheng (Author), Leo Chi Hang Tsang (Author), Tsz Chun Kwan (Author), Kaiyue Zhang (Author), Xiwei Wang (Author), Wenwei Tu (Author), Malik Peiris (Author), Yu Lung Lau (Author), Jaime S. Rosa Duque (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The durability of the immunogenicity elicited by three doses of mRNA-based BNT162b2 and whole-virus inactivated CoronaVac in patients with neuromuscular diseases, particularly those on immunosuppressive drugs and variants of concern, has not been well-established. Our goal was to evaluate medium-ter...